These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5690501)

  • 21. The effects of some hallucinogenic drugs upon the metabolism of noradrenaline.
    Leonard BE; Tonge SR
    Life Sci; 1969 Aug; 8(15):815-25. PubMed ID: 5807314
    [No Abstract]   [Full Text] [Related]  

  • 22. Lack of cross-tolerance in rats among (-)delta9-trans-tetrahydrocannabinol(delta9-THC), cannabis extract, mescaline and lysergic acid diethylamide (LSD-25).
    Teresa M; Silva A; Carlini EA; Claussen U; Korte F
    Psychopharmacologia; 1968; 13(4):332-40. PubMed ID: 5722169
    [No Abstract]   [Full Text] [Related]  

  • 23. A metabolic basis for drug dependence.
    Doust JW
    Can Psychiatr Assoc J; 1974 Oct; 19(5):487-94. PubMed ID: 4609162
    [No Abstract]   [Full Text] [Related]  

  • 24. The effects of some hallucinogenic drugs upon the metabolism of 5-hydroxy-tryptamine in the brain.
    Tonge SR; Leonard BE
    Life Sci; 1969 Aug; 8(15):805-14. PubMed ID: 5807313
    [No Abstract]   [Full Text] [Related]  

  • 25. Similarities and differences between mescaline, lysergic acid diethylamide-25 (LSD) and d-amphetamine on various components of fixed interval responding in the rat.
    Tilson HA; Sparber SB
    J Pharmacol Exp Ther; 1973 Feb; 184(2):376-84. PubMed ID: 4688175
    [No Abstract]   [Full Text] [Related]  

  • 26. [Affective-cognitive structure and psychosis. New perspectives of the study of hallucination experience with psychodysleptics].
    Andreoli A
    Ann Med Psychol (Paris); 1976 Apr; 134(4):501-22. PubMed ID: 952433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of hallucinogenic drugs upon in vivo brain levels of adenine nucleotides, phosphocreatine and inorganic phosphate in the rat.
    Lewis JJ; Ritchie AP; van Petten GR
    Br J Pharmacol Chemother; 1965 Dec; 25(3):631-7. PubMed ID: 5296835
    [No Abstract]   [Full Text] [Related]  

  • 28. Antidiuresis in man following lysergic acid diethylamide and mescaline.
    Hollister LE; Kanter SL; Dronkert A
    Behav Neuropsychiatry; 1970; 2(3):50-4. PubMed ID: 4913153
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experimental psychosis after administration of benactyzine].
    Vojtĕchovský M; Vítek V; Rysánek K
    Arzneimittelforschung; 1966 Feb; 16(2):240-2. PubMed ID: 4862402
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of LSD, mescaline, and D-amphetamine on the evoked "secondary discharge".
    Roth WT
    Psychopharmacologia; 1966; 9(3):253-8. PubMed ID: 6010545
    [No Abstract]   [Full Text] [Related]  

  • 31. Correlation of rhinencephalic electrograms with behavior; a study on humans under the influence of LSD and mescaline.
    MONROE RR; HEATH RG; MICKLE WA; LLEWELLYN RC
    Electroencephalogr Clin Neurophysiol; 1957 Nov; 9(4):623-42. PubMed ID: 13480236
    [No Abstract]   [Full Text] [Related]  

  • 32. Phencyclidine, lysergic acid diethylamide, and mescaline: cerebral artery spasms and hallucinogenic activity.
    Altura BT; Altura BM
    Science; 1981 May; 212(4498):1051-2. PubMed ID: 7195070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the phenomenology of hallucinogens and schizophrenia from some autobiographical accounts.
    Kleinman JE; Gillin JC; Wyatt RJ
    Schizophr Bull; 1977; 3(4):560-86. PubMed ID: 271353
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacological studies of sleep and dreaming: chemical and clinical relationships.
    Hartmann E
    Biol Psychiatry; 1969 Jul; 1(3):243-58. PubMed ID: 4311771
    [No Abstract]   [Full Text] [Related]  

  • 35. [Various psychodysleptic substances].
    Bernik V
    Rev Paul Med; 1972 Aug; 80(2):115-7. PubMed ID: 4671580
    [No Abstract]   [Full Text] [Related]  

  • 36. The effects of combinations of ataraxics with hypnotics, LSD and iproniazid in the mouse.
    ASTON R; CULLUMBINE H
    Arch Int Pharmacodyn Ther; 1960 Jun; 126():219-27. PubMed ID: 13794884
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experimental studies on the influence of chlorpromazine, isomytal and meprobamate on the carbohydrate metabolism of isolated tissues, with special reference to the behavior of brain slices].
    KOIZUMI H
    Naika Hokan; 1961; 8():167-83. PubMed ID: 13757638
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacological and behavioral components of tolerance to LSD and mescaline in rats.
    Murray TF; Craigmill AL; Fischer GJ
    Pharmacol Biochem Behav; 1977 Sep; 7(3):239-44. PubMed ID: 928480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of short time intervals under LSD25 and mescaline.
    Mitrani L; Shekerdjiiski S; Gourevitch A; Yanev S
    Act Nerv Super (Praha); 1977 May; 19(2):103-4. PubMed ID: 888639
    [No Abstract]   [Full Text] [Related]  

  • 40. A study of LSD-serotonin central interaction.
    ZANOWIAK P; RODMAN MJ
    J Am Pharm Assoc Am Pharm Assoc; 1959 Mar; 48(3):165-8. PubMed ID: 13641044
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.